Summary of multiple linear regressionsof motivational factors on English test score. by Zhonger Wang (21238462)

Table 1_Dual variants of uncertain significance in a case of hyper-IgM syndrome: implications for diagnosis and management.docx by Nourhen Agrebi (14151222)

“…Background<p>Hyper-IgM syndrome (HIGM) is a genetic immunodeficiency characterized by elevated to normal IgM levels and decreased IgG, IgA, and IgE. The overlapping clinical presentations of different gene mutations complicate diagnosis and management.…”

Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 1_The atherogenic index of plasma is associated with an increased risk of diabetes in non-obese adults: a cohort study.docx by Jun Cao (32440)

Density differences between pre- and post-measurements for program completers (N = 160). by Anton Kurapov (11346019)

Subjects:

电针预处理通过心肌缺血损伤 棕色脂肪组织和 BMP3b/Smad1/5 通路小鼠 by Danying Qian (21730250)

Subjects: “…electroacupuncture significantly decreased…”

A Linear dose-response relationship between TyG and ICU mortality. by Weide Lin (21402811)

Box plots showing the taxa that were significantly different between thin and normal cows. by Bhuripit Saraphol (20855573)

Subjects:

Restricted cubic spline plots showing the association between changes in PAL and risk of CVD. by Haiwei Li (282229)

Subjects:

Mean muscle activation patterns across the gait cycle during walking with mediolateral (ML) forces for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke duri... by Sanne Ettema (18786312)

Mean muscle activation patterns across the gait cycle during walking with anteroposterior (AP) forces for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke d... by Sanne Ettema (18786312)

Mean muscle activation patterns across the gait cycle during walking with Body Weight Support (BWS) for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke dur... by Sanne Ettema (18786312)

Main baseline characteristics of patients included in the study. by Jie Liu (15128)

Subjects:

(A) Monthly drug costs of patients in the ESAs group and Roxadustat group. by Jie Liu (15128)

Subjects:

Study data. by Jie Liu (15128)

Subjects:

Mean hemoglobin levels of Roxadustat and ESAs groups over time. by Jie Liu (15128)

Subjects:

Morisky score for ESAs group and Roxadustat group. by Jie Liu (15128)

Subjects:

Patient flow diagram. by Jie Liu (15128)

Subjects:

Mean total cholesterol levels over time in the roxadustat group (A) and ESAs group (B) according to the statins subgroup. by Jie Liu (15128)

Subjects: